NCT07022015
- Conditions
- Digestive System Diseases, Digestive System Fistula, Digestive System Neoplasms, +16 more
- Locations
-
- Liver and GIT hospital , Minia University Minya, Egypt
Clinical trial condition
Resectable Pancreatic Cancer
Explore clinical trials studying Resectable Pancreatic Cancer. Study availability and eligibility vary by location and protocol.
17 public trials
5 recruiting studies
Resectable Pancreatic Cancer trial results
NCT05624918
- Conditions
- Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05788744
- Conditions
- Resectable Pancreatic Cancer
- Locations
-
- Aalborg Universitetshospital Aalborg, Denmark
- Aarhus Universitetshospital Aarhus, Denmark
- Copenhagen University Hospital - Rigshospitalet Copenhagen, Denmark
- Copenhagen University Hospital - Herlev and Gentofte Herlev, Denmark
NCT03492671
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- Loma Linda University Health Loma Linda, California, United States
Recruiting
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
NCT05529940
- Conditions
- Effects of Chemotherapy, Neoadjuvant Chemotherapy, Resectable Pancreatic Cancer
- Locations
-
- Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine Seoul, South Korea
- Department of Surgery, Seoul National University College of Medicine Seoul, South Korea
Not yet recruiting
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
NCT06172036
- Conditions
- Neoadjuvant Chemotherapy, Resectable Pancreatic Cancer
- Locations
-
Not specified
Active, not recruiting
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
NCT04472910
- Conditions
- Resectable Pancreatic Cancer
- Locations
-
- BC Cancer Agency Vancouver Vancouver, British Columbia, Canada
- Kingston Health Sciences Centre Kingston, Ontario, Canada
- London Health Sciences Centre London, Ontario, Canada
- Ottawa Hospital Ottawa, Ontario, Canada
Active, not recruiting
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
NCT05209074
- Conditions
- Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Cancer
- Locations
-
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT06978322
- Conditions
- Management, Neoadjuvant Chemotherapy, Resectable Pancreatic Cancer, +1 more
- Locations
-
- Minia University Minya, Minya Governorate, Egypt
NCT03138720
- Conditions
- Neoadjuvant Pancreatic Cancer, Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer, +1 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States